• HOME (current)
  • MEETINGS ARCHIVE
    2019 RANZCO 2018 RANZCO 2017 RANZCO 2016 RANZCO 2015 RANZCO 2014 RANZCO 2013 RANZCO 2012 RANZCO
  • ADVANCED SEARCH
  • 2016 RANZCO HANDBOOK
Home > 2019 RANZCO > Cornea

Session : Cornea


SESSION INFORMATION

Date:      -

Time:      -

Meeting: 2019 RANZCO

ABSTRACT NUMBER : A33
Keratoplasty nightmares: how to avoid and manage challenging surgical scenarios
ABSTRACT NUMBER : A34
Epidermal fatty acid‐binding protein (E‐FABP): A novel biomarker in the diagnosis of dry eye disease – The experience from the non‐obese diabetic (NOD) mice
ABSTRACT NUMBER : A35
Efficacy and safety of Conjunctival Cystectomy using high‐frequency radio‐wave electrosurgery
ABSTRACT NUMBER : A36
Demographic and clinical profile, surgical outcome and quality of life in patients who underwent bilateral lamellar corneal grafts
ABSTRACT NUMBER : A37
Xtra focus pinhole IOL(Morchers GMBH) a novel approach for anterior segmentreconstruction addressing irregular astigmatism and irregular pupils
ABSTRACT NUMBER : A38
The spectrum of Microbial Keratitis: An updated review
ABSTRACT NUMBER : A39
The Keratitis Anti‐microbial Resistance Surveillance Program (KARSP): Results from 2017‐2018
ABSTRACT NUMBER : A40
Evaluation and sustainability of guidelines for the management of herpes simplex keratitis at the Sydney Eye Hospital
ABSTRACT NUMBER : A41
Microbial keratitis in Australia and New Zealand: A meta‐analysis
ABSTRACT NUMBER : A42
The octopus strap – friend or foe? Recent trends in octopus strap related eye injuries in Melbourne, Victoria
Advanced Search

MOST VIEWED ABSTRACTS


  • This Week
  • This Month
  • All Time

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Through the Cloudy Lens – Outreach in the Top End

    EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT- AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    THE CLINICAL USE OF TOPICAL HYPERTONIC SALINE EYE DROPS IN A TERTIARY REFERRAL EYE CARE CENTRE IN SYDNEY, AUSTRALIA

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    VERTICAL PRISM FUSION RANGES IN A NORMAL POPULATION

RECENT MEETINGS


2019 RANZCO, 51st Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
08 November – 12 November 2019
Sydney, Australia
2018 RANZCO, 50th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
17 November - 21 November 2018
Adelaide Convention Centre, South Australia

ARCHIVES

© COPYRIGHT 2016 The Royal Australian and New Zealand College of Ophthalmologists